BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 31857679)

  • 1. Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in microcystic adnexal carcinomas.
    Chan MP; Plouffe KR; Liu CJ; Palanisamy N; Carskadon S; Zhao L; Nazarian RM; Durham AB; Johnson TM; Andea AA; Patel RM; Lowe L; Fullen DR; Brown NA; Tomlins SA; Udager AM; Harms PW
    Mod Pathol; 2020 Jun; 33(6):1092-1103. PubMed ID: 31857679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential role for targeted therapy in a subset of metastasizing adnexal carcinomas.
    Dias-Santagata D; Lam Q; Bergethon K; Baker GM; Iafrate AJ; Rakheja D; Hoang MP
    Mod Pathol; 2011 Jul; 24(7):974-82. PubMed ID: 21423156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation.
    Harms PW; Collie AM; Hovelson DH; Cani AK; Verhaegen ME; Patel RM; Fullen DR; Omata K; Dlugosz AA; Tomlins SA; Billings SD
    Mod Pathol; 2016 Mar; 29(3):240-8. PubMed ID: 26743471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potentially druggable molecular alterations in skin adnexal malignancies.
    Cavalieri S; Busico A; Capone I; Conca E; Dallera E; Quattrone P; Licitra L; Pruneri G; Bossi P; Perrone F
    J Dermatol; 2019 Jun; 46(6):507-514. PubMed ID: 31038235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis.
    Smith KJ; Williams J; Corbett D; Skelton H
    Am J Surg Pathol; 2001 Apr; 25(4):464-71. PubMed ID: 11257620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NGS Analysis Confirms Common
    Peterson C; Moore R; Hicks JL; Morsberger LA; De Marzo AM; Zou Y; Eberhart CG; Campbell AA
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL.
    Laurent C; Nicolae A; Laurent C; Le Bras F; Haioun C; Fataccioli V; Amara N; Adélaïde J; Guille A; Schiano JM; Tesson B; Traverse-Glehen A; Chenard MP; Mescam L; Moreau A; Chassagne-Clement C; Somja J; Escudié F; André M; Martin N; Lacroix L; Lemonnier F; Hamy AS; Reyal F; Bannier M; Oberic L; Prade N; Frénois FX; Beldi-Ferchiou A; Delfau-Larue MH; Bouabdallah R; Birnbaum D; Brousset P; Xerri L; Gaulard P
    Blood; 2020 Jan; 135(5):360-370. PubMed ID: 31774495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 mutations in sweat gland carcinomas.
    Biernat W; Peraud A; Wozniak L; Ohgaki H
    Int J Cancer; 1998 May; 76(3):317-20. PubMed ID: 9579565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microcystic adnexal carcinoma (sclerosing sweat duct carcinoma).
    Mayer MH; Winton GB; Smith AC; Lupton GP; Parry EL; Shagets FW
    Plast Reconstr Surg; 1989 Dec; 84(6):970-5. PubMed ID: 2587662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microcystic adnexal carcinoma of the breast: a very rare breast skin tumor.
    Yavuzer R; Boyaci M; Sari A; Ataoğlu O
    Dermatol Surg; 2002 Nov; 28(11):1092-4. PubMed ID: 12460312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Eccrine sweat gland carcinoma of the skin].
    Rütten A
    Pathologe; 2002 Jan; 23(1):79-88. PubMed ID: 11974507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A p53-JAK-STAT connection involved in myeloproliferative neoplasm pathogenesis and progression to secondary acute myeloid leukemia.
    Goyal H; Chachoua I; Pecquet C; Vainchenker W; Constantinescu SN
    Blood Rev; 2020 Jul; 42():100712. PubMed ID: 32660739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations.
    Harms PW; Hovelson DH; Cani AK; Omata K; Haller MJ; Wang ML; Arps D; Patel RM; Fullen DR; Wang M; Siddiqui J; Andea A; Tomlins SA
    Hum Pathol; 2016 May; 51():25-31. PubMed ID: 27067779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vulvar syringomas with deep extension: a potential histopathologic mimic of microcystic adnexal carcinoma.
    Kazakov DV; Bouda J; Kacerovska D; Michal M
    Int J Gynecol Pathol; 2011 Jan; 30(1):92-4. PubMed ID: 21131826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of expert pathology review in skin adnexal carcinoma diagnosis: Analysis of 2573 patients from the French CARADERM network.
    Battistella M; Balme B; Jullie ML; Zimmermann U; Carlotti A; Crinquette M; Frouin E; Macagno N; Ortonne N; Lamant L; de la Fouchardiere A; Aubriot-Lorton MH; Durand L; Josselin N; Franck F; Chatelain D; Lemasson G; Algros MP; Durlach A; Machet MC; Courville P; Osio A; Seris A; Mortier L; Jouary T; Cribier B;
    Eur J Cancer; 2022 Mar; 163():211-221. PubMed ID: 35090811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microcystic adnexal carcinoma: an immunohistochemical reappraisal.
    Hoang MP; Dresser KA; Kapur P; High WA; Mahalingam M
    Mod Pathol; 2008 Feb; 21(2):178-85. PubMed ID: 18065959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic changes in sweat gland carcinomas.
    Takata M; Hashimoto K; Mehregan P; Lee MW; Yamamoto A; Mohri S; Ohara K; Takehara K
    J Cutan Pathol; 2000 Jan; 27(1):30-5. PubMed ID: 10660129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALPK1 hotspot mutation as a driver of human spiradenoma and spiradenocarcinoma.
    Rashid M; van der Horst M; Mentzel T; Butera F; Ferreira I; Pance A; Rütten A; Luzar B; Marusic Z; de Saint Aubain N; Ko JS; Billings SD; Chen S; Abi Daoud M; Hewinson J; Louzada S; Harms PW; Cerretelli G; Robles-Espinoza CD; Patel RM; van der Weyden L; Bakal C; Hornick JL; Arends MJ; Brenn T; Adams DJ
    Nat Commun; 2019 May; 10(1):2213. PubMed ID: 31101826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma.
    Jedrych J; McNiff JM
    Am J Dermatopathol; 2013 May; 35(3):308-15. PubMed ID: 23598854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent Oncogenic JAK and STAT Alterations in Cutaneous CD30-Positive Lymphoproliferative Disorders.
    Maurus K; Appenzeller S; Roth S; Brändlein S; Kneitz H; Goebeler M; Rosenwald A; Geissinger E; Wobser M
    J Invest Dermatol; 2020 Oct; 140(10):2023-2031.e1. PubMed ID: 32147503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.